TScan Therapeutics Inc (TCRX)

[FACT-MASTER]

cont'd Webcast Details

TScan will host a webcast Thursday, May 19, 2022, at 4:30 p.m. ET. The event will provide a summary of the ASGCT posters and oral presentation as well as a discussion of TScan’s solid tumor programs. The featured speaker will be Kai Wucherpfennig, M.D., Ph.D., Chair, Cancer Immunology and Virology and Director, Center for Cancer Immunology Research at the Dana-Farber Cancer Institute, Professor of Neurology, Brigham and Women’s Hospital and Harvard Medical School, and Associate Member, Broad Institute of MIT and Harvard. The presentation will be followed by a question-and-answer session.

The live audio webcast and accompanying slides may be accessed through the Events and Presentations page in the Investors section of the Company’s website at www.tscan.com. Registration for the event is available here. For those unable to participate in the live webcast, a replay will be available on the Investor section of the Company’s website at https://ir.tscan.com/news/events-and-presentations.